Address Patient Concerns About Impurities Found in Ranitidine and Other Meds
Patients will ask you if their meds are safe...due to headlines about a probable carcinogen in some Rx and OTC ranitidine products.
The buzz is about N-nitrosodimethylamine (NDMA)...the impurity that first sparked recalls of irbesartan, losartan, and valsartan.
Now FDA is investigating how much NDMA is in ranitidine...whether it poses any risk...and the source. In fact, one independent analysis used high temps to test ranitidine...and the test itself generated NDMA.